Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes.

1. Allergic Rhinitis
MARKET INSIGHT, EPIDEMIOLOGY AND MARKET
FORECAST 2027
1

2. Allergic Rhinitis
Allergic rhinitis, also known as hay fever, is a type
of inflammation in the nose which occurs when
the immune system overreacts to allergens in the
air. Signs and symptoms include a runny or stuffy
nose, sneezing, red, itchy, and watery eyes, and
swelling around the eyes.
2

3. Allergic rhinitis 3
Genetic and environmental factors
Stuffy nose, sneezing, red, itchy and watery eyes, swelling
around the eyes
~20% ( Western countries )
Allergy and immunology

4. Classification 4
01
02
03
Allergic rhinitis may be seasonal or perennial.
Perennial allergic rhinitis occurs throughout the year.
This type of allergic rhinitis is commonly seen in
younger children.
04
It may also be classified as Mild-Intermittent,
Moderate-Severe intermittent, Mild-Persistent, and
Moderate-Severe Persistent.
Seasonal allergic rhinitis occurs in particular during
pollen seasons. It does not usually develop until after
6 years of age.

5. Market Insights 5
Market size of allergic
rhinitis in the US was found
to be xxx in 2016.
The market size of allergic
rhinitis shall increase at a
CAGR of XX% during forecast
period (2018-2027)
Pharmacotherapy and
immunotherapy are
recommended for treating
Allergic RhinitisLaunch of therapies such as
Omalizumab (Novartis
Pharmaceuticals) and GSP 301
(Glenmark Pharma) shall fuel the
growth of the market.
Targeted
immunotherapy is
effective in changing
the natural course of
Allergic Rhinitis.

6. Emerging Therapy Analysis 6
Omalizumab GSP 301
Launch of emerging
therapies such as
Omalizumab
(Novartis
Pharmaceuticals)
GSP 301 (Glenmark
Pharmaceuticals Ltd)
And other effective therapies, are expected to change the treatment landscape of Allergic Rhinitis
in upcoming years.

7. COMPLETE INFORMATION 7
For complete information please click the link below
Or
write us at
info@delveinsight.com
CLICK HERE

8. ABOUT DELVEINSIGHT
Insight across value chain to help organization make important business
decision through the use and analysis of actionable market intelligence.
8
ABOUT
DELVEINSIGHT
MISSION
VISION
• Delveinsight , market research & consulting firm provides end to end
comprehensive solutions to the life science industry.
• We help our customers in best decision-making through our expertise in
research & analysis & comes out with unmatched data & forecasts.
• To be the most trusted market research & business consulting
firm worldwide.
• To be the renowned & premier data driven solutions providers
among pharma & biotech companies.

9. 9
Contact us :
info@delveinsight.com
+91-11-45689769
www.delveinsight.com
blog/delveinsight/
twitter/delveinsight/
Linkedin/delveinsight
c